Atrogi AB: Clinical Trials

3 trials sponsored by Atrogi AB, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Active not recruiting 1

Follow Atrogi AB: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GRK-Biased Activation Via β2-Adrenergic Receptors in Human Skeletal Muscle
ATR-258 - Overweight and Obesity
Phase 2Active not recruitingMorten Hostrup, PhD132026-02-192026-10-14
The Attractive 2 Trial - Pharmacokinetics of ATR-258 Oral Capsule vs. Oral Solution Formulations in Healthy Volunteers
ATR-258 Oral solution, ATR-258 Oral capsule - Type2diabetes
Phase 1CompletedAtrogi AB212024-04-242024-07-01
First-in-human Single and Multiple Dose Trial of ATR-258
ATR-258 - Type 2 Diabetes Mellitus
Phase 1CompletedAtrogi AB712022-04-112023-12-18

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Obesity (1)  ·  Overweight (1)

Countries

Denmark (1)  ·  Germany (1)  ·  Sweden (1)

Top investigators

Erik Waara (1)

NIH funding

2023 (1)